Reproductive Health
Leverage technology to reach women in ‘double deserts’ needing cardio-obstetric care
Cardio-obstetrics care is often out of reach for women living in underserved rural areas, but there are steps cardiologists and OB/GYNs can take to ensure pregnant people have healthy deliveries despite geographic disparities.
Medication abortion via telemedicine in primary care found to be effective, trustworthy
Telemedicine medication abortion services in primary care were well received by patients thanks to clear communication and previously established relationships, researchers found.
Patients with later menarche, earlier menopause have higher risk for rheumatoid arthritis
Menarche after the age of 14 years, or going through menopause before 45 years of age, are among the hormonal and reproductive factors that increase the risk for rheumatoid arthritis, according to data published in RMD Open.
OB/GYNs feel effect of US abortion bans on workforce, personal health, patient care
Based on interviews with 54 self-selected OB/GYNs, researchers reported in JAMA Network Open that OB/GYNs experienced “deep and pervasive” impacts from state abortion bans on workforce sustainability, physician health and patient outcomes.
Poor ovarian response to stimulation linked to higher rates of oocyte cryopreservation use
Women with poor ovarian response to stimulation had higher likelihood of using frozen oocytes after planned cryopreservation vs. women normal response, particularly among women aged 30 to 39 years, according to cohort study results.
E-cigarette use does not raise risk for small neonates among pregnant teens
Among adolescents, e-cigarette use during late pregnancy was not statistically significantly associated with an increased small for gestational age birth risk, but cigarette use was, researchers reported in JAMA Network Open.
Maternal cannabis use linked to adverse pregnancy outcomes related to placental function
Maternal cannabis use was associated with adverse pregnancy outcomes, including small for gestational age, preterm birth, stillbirth and hypertensive disorders of pregnancy, linked to placental function, researchers reported in JAMA.
Top 10 in 2023: Women in Oncology’s most-read stories of the year
Women in oncology continued to break barriers, unveil new research and accomplish goals in 2023.
Obstetric outcomes unaffected by maintaining TNF inhibition during pregnancy
SAN DIEGO — In patients with chronic rheumatic inflammatory disease, those who continue TNF inhibition during pregnancy have similar obstetrical outcomes as those who cease treatment, according to data presented at ACR Convergence 2023.
Three-quarters of patients in RA remission flare within 3 years of TNF inhibitor taper
SAN DIEGO — Approximately 75% of patients in rheumatoid arthritis remission who taper TNF inhibitors to withdrawal experience a flare within 3 years, according to data presented at ACR Convergence 2023.